Great News India launched drug for treating covid-19
India's Glenmark Pharmaceutical Company today announced that it has made a drug for treating covid-19
India's Glenmark Pharmaceutical Company today announced that it has made a drug for treating covid-19, which is trembling the world.
Antiviral medicine is currently working on the Faviprovir covid treatment, which will be launched in the market with the brand name Fabifluom, says Glenmark Pharmaceutical.
The 'Favipiravar' drug has been working well The Fabiflu tablet 200MG is available in the market for Rs103.Corona patients should use this drug for a total of 14 days Glenmark Pharmaceutical Company Chairman and MD Glenn Saldanha explained that the strip with 34 tablets will be available in the market for Rs 3,500
The 'Favipiravar' drug has been working well on covid-19 patients in their clinical trials, said Glenmark Pharmaceutical Company Chairman and MD Glenn Saldanha.
At present 82,500 are preparing to manufacture fabiflu tablets in first month and the country is going to increase production capacity based on the virus situation said Glenmark pharmaceutical company chairman and MD Glenn saldanha
